{"data":[{"accessionNo":"0001104659-26-097206","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":10215455,"percentOfClass":9.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097206","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":10215455,"percentOfClass":9.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097206","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":10215455,"percentOfClass":9.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097206","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":8961631,"percentOfClass":8.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-26-000922","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8392730,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-26-000922","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":8392730,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-26-000922","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":8392730,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-26-000922","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":8392730,"percentOfClass":7.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097041","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Baker Bros. Advisors LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3701719,"percentOfClass":3.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097041","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Felix J. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":3701719,"percentOfClass":3.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097041","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Julian C. Baker","reportingCik":null,"personType":"HC,IN","sharesOwned":3701719,"percentOfClass":3.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-097041","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Baker Bros. Advisors (GP) LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":3701719,"percentOfClass":3.4,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0000315066-26-001979","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001710072","issuerName":"EDGEWISE THERAPEUTICS INC","ticker":"EWTX","cusip":"28036F105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":5489135,"percentOfClass":5.1,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0000315066-26-001979","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001710072","issuerName":"EDGEWISE THERAPEUTICS INC","ticker":"EWTX","cusip":"28036F105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":5489135,"percentOfClass":5.1,"filedAt":"2026-08-06","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001274173-26-000124","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001710072","issuerName":"EDGEWISE THERAPEUTICS, INC.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":5915556,"percentOfClass":5.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001388325-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":"28036F105","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-23","reportingPerson":"Novo Holdings A/S","reportingCik":"0001388325","personType":"CO","sharesOwned":5350000,"percentOfClass":4.9,"filedAt":"2026-04-27","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-016362","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Paradigm BioCapital Advisors LP","reportingCik":null,"personType":"PN","sharesOwned":6541210,"percentOfClass":6.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-016362","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Paradigm BioCapital Advisors GP LLC","reportingCik":null,"personType":"OO","sharesOwned":6541210,"percentOfClass":6.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-016362","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Senai Asefaw, M.D.","reportingCik":null,"personType":"IN","sharesOwned":6541210,"percentOfClass":6.2,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001104659-26-016362","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2025-12-31","reportingPerson":"Paradigm BioCapital International Fund Ltd.","reportingCik":null,"personType":"CO","sharesOwned":5778924,"percentOfClass":5.5,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-25-000488","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":10428437,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-25-000488","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":10428437,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-25-000488","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":10428437,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001231919-25-000488","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001710072","issuerName":"Edgewise Therapeutics, Inc.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10428437,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"},{"accessionNo":"0001274173-25-000268","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001710072","issuerName":"EDGEWISE THERAPEUTICS, INC.","ticker":"EWTX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":4979331,"percentOfClass":4.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx"}],"updatedAt":"2026-11-05T14:26:15.252Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ewtx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}